Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice. conference hero image

Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.

Accreditation: 9.00 AMA PRA Category 1 Credit™ | 9.00 ABIM MOC II | 9.00 Nursing Contact Hours | 9.00 ACPE Pharmacy

Venue: Hyatt Regency Salt Lake City, 170 South West Temple Street, Salt Lake City, UT, 84101, United States

Start Date: End Date:
Register for Conference

Official conference page for Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice..

About Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Srinivas Tantravahi
Amy Sharp
31+

Faculty and committee

Our Speakers

Conference program and agenda

Agenda

Day 1: Friday, September 18th, 2026

All timings are in Mountain Time (MDT, GMT-06:00) time.

12:00 PM - 01:00 PMRegistration, Lunch & Exhibits
01:00 PM - 01:05 PMWelcome
01:05 PM - 02:35 PMSession 1: Acute Leukemia

Session Chair: Srinivas Tantravahi, MBBS

01:05 PM - 01:20 PM

How I Treat Acute Myeloid Leukemia in 2026

01:20 PM - 01:35 PM

How I Treat Acute Lymphoblastic Leukemia in 2026 Adam DuVall, MD

01:35 PM - 01:45 PM

Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia Sankalp Arora

01:45 PM - 02:35 PM

Q&A and Discussion

Moderators:

Srinivas Tantravahi, MBBS

Panelists:

Adam DuVall, MD; Zaker Schwabkey, MD; Sankalp Arora

02:35 PM - 02:50 PMBreak and Exhibits
02:50 PM - 04:20 PMSession 2: Aggressive Lymphoma

Session Chair: Daniel Arthur Ermann, MD

02:50 PM - 03:05 PM

Evolving Treatment Landscape in Newly Diagnosed Large B-Cell Lymphoma Harsh Shah, DO

03:05 PM - 03:20 PM

How I Treat R/R Large B-Cell Lymphoma in 2026 Richard T. Maziarz, MD

03:20 PM - 04:00 PM

Panel Discussion: Practical Decision-Making in Community Practice

03:50 PM - 04:20 PM

Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia

04:00 PM - 04:20 PM

Case Based Panel Discussion

Moderators:

Daniel Arthur Ermann, MD

Panelists:

Richard T. Maziarz, MD; Banu Symington, MD; Harsh Shah, DO

04:20 PM - 04:20 PMAdjourn Day 1

Day 2: Saturday, September 19th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, and Exhibits
08:00 AM - 08:05 AMWelcome
08:05 AM - 08:25 AMBinaytara’s Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:25 AM - 09:55 AMSession 3A: Low-grade Lymphoma & CLL

Session Chair: Xylina Gregg, MD

08:25 AM - 08:40 AM

How I Treat Indolent Lymphoma in 2026 Narendranath Epperla, MD

08:40 AM - 08:55 AM

How I Treat Chronic Lymphocytic Leukemia (CLL) in 2026 Daniel Arthur Ermann, MD

08:55 AM - 09:05 AM

Q&A and Discussion

09:05 AM - 09:15 AM

Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Low-grade Lymphoma & CLL

09:15 AM - 09:55 AM

Case Discussion: The Gray Zone – Controversy and Clinical Judgement in Low-grade Lymphoma & CLL

Moderators:

Xylina Gregg, MD

Panelists:

Narendranath Epperla, MD; Daniel Arthur Ermann, MD

09:05 AM - 09:55 AMSession 3B: CAR-T and Cellular Therapy Toxicity Management

Session Chair: Amanda Dailey-Hansen, DNP

09:05 AM - 09:25 AM

CAR-T Toxicity Christopher Cahoon, PharmD

09:25 AM - 09:55 AM

Q&A and Discussion

Moderators:

Amanda Dailey-Hansen, DNP

Panelists:

Christopher Cahoon, PharmD; Brian Burnham, PharmD; Amy Maggie Sharp, BSN

09:55 AM - 10:25 AMBreaks & Exhibits

Venue and map

Accreditations and continuing education

Acknowledgement of Commercial Support

This activity is supported with an Independent Medical Education grant from Pfizer.

Accreditation

Registration and pricing

Exhibitors and sponsorship